<DOC>
	<DOCNO>NCT00074620</DOCNO>
	<brief_summary>The study look safety profile ( unwanted effect ) long-lasting anticoagulant PEG-hirudin ( SPP200 ) compare unwanted effect unfractionated heparin , commonly use haemodialysis avoid clot graft haemodialysis machine .</brief_summary>
	<brief_title>A Clinical Study Assess Safety PEG-Hirudin ( SPP200 ) Compared Heparin Patients Who Are Haemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Graft Occlusion , Vascular</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Patients undergo chronic haemodialysis via arteriovenous graft Arteriovenous graft place least 3 month Duration haemodialysis least 3 month , 3 full dialysis session per week duration 2 5 hour per session Women patient must either postmenopausal 1 year , childbearing age , must use adequate contraception Women patient must negative serum pregnancy test within one week randomisation Able provide write informed consent prior study participation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Haemodialysis</keyword>
	<keyword>PEG-Hirudin</keyword>
	<keyword>Vascular graft occlusion</keyword>
	<keyword>Renal replacement therapy</keyword>
	<keyword>Hemodialysis</keyword>
</DOC>